IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i8p4024-d534266.html
   My bibliography  Save this article

Effects of a Mixture of Ivy Leaf Extract and Coptidis rhizome on Patients with Chronic Bronchitis and Bronchiectasis

Author

Listed:
  • Goohyeon Hong

    (Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan 31116, Korea)

  • Yu-Il Kim

    (Department of Internal Medicine, Division of Pulmonology, Chonnam National University Hospital, Chonnam 61469, Korea)

  • Seoung Ju Park

    (Department of Internal Medicine, Division of Pulmonology, Allergy and Critical Care Medicine, Jeonbuk National University Medical School, Cheonbuk 54907, Korea)

  • Sung Yong Lee

    (Department of Internal Medicine, Division of Pulmonology, Allergy and Critical Care Medicine, Korea University Guro Hospital, Seoul 08308, Korea)

  • Jin Woo Kim

    (Department of Internal Medicine, Division of Pulmonology, College of Medicine, The Catholic University, Uijeongbu 11765, Korea)

  • Seong Hoon Yoon

    (Department of Internal Medicine, Division of Pulmonology, Pusan National University Yangsan Hospital, Pusan 49241, Korea)

  • Keu Sung Lee

    (Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Ajou University Hospital, Suwon 16499, Korea)

  • Min Kwang Byun

    (Department of Internal Medicine, Division of Respiratory Medicine, Gangnam Severance Hospital, Seoul 06273, Korea)

  • Hak-Ryul Kim

    (Department of Internal Medicine, Division of Respiratory Medicine, Wonkwang University Hospital, Iksan 54538, Korea)

  • Jaeho Chung

    (Department of Internal Medicine, Division of Respiratory Medicine, Catholic Kwandong University International St. Mary’s Hospital, Incheon 22711, Korea)

Abstract

Background: Hederacoside C from ivy leaf dry extracts (HH) and berberine from Coptidis rhizome dry extracts (CR) can be combined (HHCR) as a herbal product. Previous studies have demonstrated that HHCR has antitussive and expectorant effects in animal models of respiratory disease. However, the therapeutic effects of HHCR on respiratory diseases in humans have not been well-studied. Therefore, we aimed to clarify the effectiveness of HHCR in patients with chronic bronchitis and bronchiectasis. Methods: This was a multicenter (10 university teaching hospitals), open-label, prospective, single-arm, observational study. Consecutive patients with chronic bronchitis and bronchiectasis were included. Patients were orally treated with HHCR daily for 12 weeks. St. George’s Respiratory Questionnaire (SGRQ) scores and bronchitis severity scores (BSS) were measured at baseline and at the end of the 12-week study. Results: In total, 376 patients were enrolled, of which 304 were finally included in the study, including 236 males and 68 females with a median age of 69 years (range: 37–88 years). After 12 weeks of HHCR treatment, there was a significant improvement in SGRQ score (baseline, 32.52 ± 16.93 vs. end of study, 29.08 ± 15.16; p < 0.0001) and a significant reduction in BSS (baseline, 7.16 ± 2.63 vs. end of study, 4.72 ± 2.45; p < 0.0001). During the study, 14 patients concomitantly used an inhaled corticosteroid and 83 patients used an inhaled bronchodilator. HHCR also had significant positive effects on these patients in terms of SGRQ score and BSS. No serious adverse drug reactions occurred during HHCR treatment. Conclusions: treatment with HHCR improved the SGRQ score and BSS in patients with chronic bronchitis and bronchiectasis. HHCR may be a new therapeutic option for chronic bronchitis and bronchiectasis. Large-scale, randomized, double-blind, placebo-controlled clinical trials are warranted.

Suggested Citation

  • Goohyeon Hong & Yu-Il Kim & Seoung Ju Park & Sung Yong Lee & Jin Woo Kim & Seong Hoon Yoon & Keu Sung Lee & Min Kwang Byun & Hak-Ryul Kim & Jaeho Chung, 2021. "Effects of a Mixture of Ivy Leaf Extract and Coptidis rhizome on Patients with Chronic Bronchitis and Bronchiectasis," IJERPH, MDPI, vol. 18(8), pages 1-12, April.
  • Handle: RePEc:gam:jijerp:v:18:y:2021:i:8:p:4024-:d:534266
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/8/4024/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/18/8/4024/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:8:p:4024-:d:534266. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.